Je-Hee Jeon
Yonsei University · Medicine
About the Lab
Professor Je-Hee Jeon's research lab specializes in advanced retinal and renal disease modeling using cutting-edge in vivo imaging techniques, with a focus on understanding the dynamic pathophysiology of microvascular and immune responses in diseases such as uveitis, chronic kidney disease, and retinal ischemia. The lab employs multimodal imaging approaches—including two-photon intravital microscopy, OCT angiography, and in vivo confocal imaging—to visualize cellular and vascular changes in real time, enabling longitudinal analysis of disease progression. A key research direction involves investigating microglial heterogeneity and vascular permeability in retinal disorders, as well as developing targeted imaging probes for early detection of pathological neovascularization in age-related macular degeneration.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15We aimed to characterize the vascular phenotypes of an experimental autoimmune retinal uveitis (EAU) model induced by interphotoreceptor retinoid-binding protein (IRBP) using multimodal imaging techniques. We systemically administered IRBP or vehicle to adult C57BL/6 mice. Fundus photography, optical coherence tomography (OCT), in vivo live confocal imaging using different tracers, OCT angiography (OCTA), and electroretinography (ERG) were performed after IRBP immunization. Hematoxylin and eosin
Chronic kidney disease (CKD) is one of the most common renal diseases manifested by gradual loss of kidney function with no symptoms in the early stage. The underlying mechanism in the pathogenesis of CKD with various causes such as high blood pressure, diabetes, high cholesterol, and kidney infection is not well understood. In vivo longitudinal repetitive cellular-level observation of the kidney of the CKD animal model can provide novel insights to diagnose and treat the CKD by visualizing the
This technological method could be a valuable assessment tool to help the development of novel therapeutics for retinal diseases.
Introduction: The classically defined two retinal microglia layers are distributed in inner and outer plexiform layers. Although there are some reports that retinal microglia are also superficially located around the ganglion cell layer (GCL) in contact with the vitreous, there has been a lack of detailed descriptions and not fully understood yet. Methods: We visualized the microglial layers by using CX3CR1-GFP (C57BL6) transgenic mice with both healthy and disease conditions including NaIO3-ind
Animal models of retinal artery occlusion (RAO) have been widely used in many studies. However, most of these studies prefer using a central retinal artery occlusion (CRAO) which is a typical global ischemia model of the retina, due to the technical limitation of producing single vessel targeted modeling with real-time imaging. A focal ischemia model, such as branch retinal artery occlusion (BRAO), is also needed for explaining interactions, including the immunological reaction between the ische
The development of choroidal neovascularization (CNV) is a crucial factor in the pathophysiology and prognosis of exudative age-related macular degeneration (AMD). Therefore, the detection of CNV is essential for establishing an appropriate diagnosis and treatment plan. Current ophthalmic imaging techniques, such as fundus fluorescent angiography and optical coherence tomography, have limitations in accurately visualizing CNV lesions and expressing CNV activity, owing to issues such as excessive
Oral mucosa is a soft tissue lining the inside of the mouth, protecting the oral cavity from microbiological insults. The mucosal immune system is composed of diverse types of cells that defend against a wide range of pathogens. The pathophysiology of various oral mucosal diseases has been studied mostly by ex vivo histological analysis of harvested specimens. However, to analyze dynamic cellular processes in the oral mucosa, longitudinal in vivo observation of the oral mucosa in a single mouse
Glutamate, a crucial player in hepatic amino acid metabolism, has been relatively unexplored in immune cell activation. We show in a study with male mice that hepatic glutamate accumulates in vesicles of perivenous hepatocytes through vesicular glutamate transporter 3 (VGLUT3), regulated by the aryl hydrocarbon receptor upon chronic alcohol intake. Additional binge drinking triggers the exocytosis of glutamate by altering the intracellular Ca2+ level, stimulating metabotropic glutamate receptor
BACKGROUND/AIMS: Circumscribed choroidal haemangioma (CCH) can cause visual impairment, primarily managed with photodynamic therapy (PDT). This study aimed to identify predictive factors of therapeutic response in patients with CCH treated with PDT and to analyse serial anatomical outcomes, focusing on visual acuity, tumour characteristics, and inner retinal microstructures. METHODS: This retrospective study included patients diagnosed with CCH at Severance Eye Hospital, Yonsei University, from
In dental pulp, diverse types of cells mediate the dental pulp immunity in a highly complex and dynamic manner. Yet, 3D spatiotemporal changes of various pulpal immune cells dynamically reacting against foreign pathogens during immune response have not been well characterized. It is partly due to the technical difficulty in detailed 3D comprehensive cellular-level observation of dental pulp in whole intact tooth beyond the conventional histological analysis using thin tooth slices. In this work,
Longitudinal cellular-level imaging of pancreatic tumor microenvironment at the same site in the pancreas of preclinical mouse model was achieved by using intravital dual-mode two- photon and confocal microscope combined with pancreas imaging window.
Purpose: To evaluate the anatomical and visual effects of biosimilars in the treatment of wet age-related macular degeneration (AMD).Methods: We retrospectively reviewed patients with wet AMD treated with originator or biosimilar ranibizumab (CKD-701) or aflibercept (SB15) between June 2024 and February 2025 at Severance Eye Hospital.Clinical outcomes were assessed over six months using best corrected visual acuity (BCVA) and central macular thickness (CMT) measurements.Results: Among 272 patien
Research Areas
Dive deeper into Je-Hee Jeon's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.